Review
Year 2017,
Volume: 9 Issue: 1, 11 - 15, 25.01.2017
Abstract
Abstract
Asthma is a chronic inflammatory disease of the airways that is accompanied byrecurrent coughing and wheezing episodes, usually with bronchial hyperreactivityand in the foreground eosinophils and mast cells and improving with or without treatment. The prevalence of asthma is found to range between 2-15% in children and 2-5% in adults. According to the “Global Initiative for Asthma”, asthma management is an important step in ensuring the education and regular follow-up of patients in the management strategy. Treatment is considered to be the most importantcause of difficult asthma treatment discordance. In this review, we present the reasonsand solutions that affect compliance in asthma treatment.
Keywords
References
- Kaynaklar 1.Scichilone N, Contino A, Figlioli GB, Paglino G, Bellia V. Pa-tient perspectives in the management of asthma: improving pa-tient outcomes through critical selection of treatment options.Patient Prefer Adherence 2010; 4: 17-23. 2.Bhopal RS. The inter-relationship of folk, traditional and wes-tern medicine with an Asian community in Britain. Soc Sci Med1986; 22: 99-105. 3.Hatton MQF, Allen MB, Vathenen SV, et al. Compliance withoral corticosteroids during steroid trials in chronic airwaysobstruction. Thorax 1996; 51: 323-24. 4.Strong S, Rigby P, Stewart D, Law M, Letts L, Cooper B. App-lication of the person-environment-occupation model: apractical tool. Can J Occup Ther 1999; 66 (3): 122-33. 5.Anarella J, Roohan P, Balistreri E, et al. 2004. A survey ofMedicaid recipients with asthma: perceptions of self-mana-gement, access, and care. Chest 2004; 125: 1359–67. 6.Kalichman SC, Ramachandran B, Catz S. Adherence tocombination antiretroviral therapies in HIV patients of lowhealth literacy. J Gen Intern Med. 1999; 14 (5): 267-73. 7.Bosley CM, Fosbury JA, Cochrane GM. The psychological fac-tors associated with poor compliance with treatment in asth-ma. Eur Respir J 1995; 8: 899-904. 8.Miller WR. Motivation for treatment: a review with special emp-hasis on alcoholism. Psychol Bull 1985; 98: 84-107. 9.Keller S. Implications of the Stages of Change model for me-dication compliance. Eur Respir Rev (inpress). 10.Prochaska JO. Strong and weak principles for progressing fromprecontemplation to action on the basis of twelve problem be-haviors. Health Psychol 1994; 13: 47-51. 11.Baiardini I, Braido F, Giardini A, et al. Adherence to treat-ment: assessment of an unmet need in asthma. J Investig Al-lergol Clin Immunol 2006; 16: 218–23. 12.Bender BG. Risk taking, depression, adherence, and symptomcontrol in adolescence and young adults with asthma. Am JRespir Crit Care Med 2006; 173: 953–57. 13.Harding JM, Modell M. How patients manage asthma. J R CollGen Pract 1985; 35: 226-28. 14.Creer TL, Levstek D. Medication compliance and asthma:overlooking the trees because of the forest. J Asthma 1996;33: 203-11. 15.Ozturk AB, Ozyigit Pur L, Kostek O, Keskin H. Associationbetween asthma self-management knowledge and asthma con-trol in the elderly. Ann Allergy Asthma Immunol 2015; 114(6): 480-84. 16.Lasmar LM, Camargos PA, Costa LF, et al. Compliance withinhaled corticosteroid treatment: rates reported by guardiansand measured by the pharmacy. J Pediatr (Rio J) 2007; 83:471e6. 17.Rand CS, Wise RA. Measuring adherence to asthma me-dication regimens. Am J Respir Crit Care Med 1994; 149:s69–76.18.Cramer JA, Mattson RH, Prevey ML, Scheyer RD, OuelletteVL. How often is medication taken as prescribed? A novel as-sessment technique. JAMA 1989; 261 (22): 3273–77. 19.Rand CS, Nides M, Cowles MK, et al. Long-term metered-doseinhaler adherence in a clinical trial. Am J Respir Crit CareMed 1995; 152: 580-88. 20.De Marco R, Cazzoletti L, Cerveri I, et al. Are the asthma gui-deline goals achieved in daily practice? A population basedstudy on treatment adequacy and the control of asthma. IntArch Allergy Immunol 2005; 138 (3): 225–34. 21.Foden J, Hand CH. Does use of a corticosteroid/long-actingbeta-agonist combination inhaler increase adherence to inha-led corticosteroids? Prim Care Respir J 2008; 17: 246e7. 22.Laube BL, Janssens HM, de Jongh FH, et al. What the pul-monary specialist should know about the new inhalation the-rapies. Eur Respir J 2011; 37: 1308e31. 23.Starobin D, Bargutin M, Rosenberg I, Yarmolovsky A, LeviT, Fink G. Asthma control and compliance in a cohort of adultasthmatics: first survey in Israel. IMAJ 2007; 9: 358–60. 24.Chapman KR, Walker L, Cluley S, Fabbri L. Improving patientcompliance with asthma therapy. Respir Med 2000; 94 (1): 2-9. 25.Sclaeppi M, Edwards K, Fuller RW, et al. Patient percepti-on of the Diskus inhaler. A comparison with the Turbuhalerinhaler. Br J Clin Pract 1996; 50: 14-19. 26.Burger M. Negative reactions to increases in perceived per-sonal control. J Pers Soc Psychol 1989; 56: 346-56.
Year 2017,
Volume: 9 Issue: 1, 11 - 15, 25.01.2017
Abstract
Öz
Astım, tekrarlayan öksürük hışıltı atakları ile seyreden, tedavi ile veya tedavisiz düzelebilen, genellikle bronş hiper reaktivitesinin eşlik ettiği, eozinofil ve mast hücrelerinin ön planda olduğu hava yollarının kronik inflamatuvar hastalığıdır. Astım prevalansının çocuklarda %2-15 ve erişkinlerde ise %2-5 arasında dağılım gösterdiği görülmektedir. “The Global Initiative for Asthma” kuruluşuna göre astım yönetim stratejisinde hastaların eğitimi ve düzenli takibin sağlanmasında önemli basamaklardır.Tedavisi zor astımın en önemli sebebi tedaviye uyumsuzluk olarak değerlendirilmektedir. Bu derlememizde astım tedavisinde uyumu etkileyen nedenler ve çözüm önerilerini sunmaktayız.
Keywords
References
- Kaynaklar 1.Scichilone N, Contino A, Figlioli GB, Paglino G, Bellia V. Pa-tient perspectives in the management of asthma: improving pa-tient outcomes through critical selection of treatment options.Patient Prefer Adherence 2010; 4: 17-23. 2.Bhopal RS. The inter-relationship of folk, traditional and wes-tern medicine with an Asian community in Britain. Soc Sci Med1986; 22: 99-105. 3.Hatton MQF, Allen MB, Vathenen SV, et al. Compliance withoral corticosteroids during steroid trials in chronic airwaysobstruction. Thorax 1996; 51: 323-24. 4.Strong S, Rigby P, Stewart D, Law M, Letts L, Cooper B. App-lication of the person-environment-occupation model: apractical tool. Can J Occup Ther 1999; 66 (3): 122-33. 5.Anarella J, Roohan P, Balistreri E, et al. 2004. A survey ofMedicaid recipients with asthma: perceptions of self-mana-gement, access, and care. Chest 2004; 125: 1359–67. 6.Kalichman SC, Ramachandran B, Catz S. Adherence tocombination antiretroviral therapies in HIV patients of lowhealth literacy. J Gen Intern Med. 1999; 14 (5): 267-73. 7.Bosley CM, Fosbury JA, Cochrane GM. The psychological fac-tors associated with poor compliance with treatment in asth-ma. Eur Respir J 1995; 8: 899-904. 8.Miller WR. Motivation for treatment: a review with special emp-hasis on alcoholism. Psychol Bull 1985; 98: 84-107. 9.Keller S. Implications of the Stages of Change model for me-dication compliance. Eur Respir Rev (inpress). 10.Prochaska JO. Strong and weak principles for progressing fromprecontemplation to action on the basis of twelve problem be-haviors. Health Psychol 1994; 13: 47-51. 11.Baiardini I, Braido F, Giardini A, et al. Adherence to treat-ment: assessment of an unmet need in asthma. J Investig Al-lergol Clin Immunol 2006; 16: 218–23. 12.Bender BG. Risk taking, depression, adherence, and symptomcontrol in adolescence and young adults with asthma. Am JRespir Crit Care Med 2006; 173: 953–57. 13.Harding JM, Modell M. How patients manage asthma. J R CollGen Pract 1985; 35: 226-28. 14.Creer TL, Levstek D. Medication compliance and asthma:overlooking the trees because of the forest. J Asthma 1996;33: 203-11. 15.Ozturk AB, Ozyigit Pur L, Kostek O, Keskin H. Associationbetween asthma self-management knowledge and asthma con-trol in the elderly. Ann Allergy Asthma Immunol 2015; 114(6): 480-84. 16.Lasmar LM, Camargos PA, Costa LF, et al. Compliance withinhaled corticosteroid treatment: rates reported by guardiansand measured by the pharmacy. J Pediatr (Rio J) 2007; 83:471e6. 17.Rand CS, Wise RA. Measuring adherence to asthma me-dication regimens. Am J Respir Crit Care Med 1994; 149:s69–76.18.Cramer JA, Mattson RH, Prevey ML, Scheyer RD, OuelletteVL. How often is medication taken as prescribed? A novel as-sessment technique. JAMA 1989; 261 (22): 3273–77. 19.Rand CS, Nides M, Cowles MK, et al. Long-term metered-doseinhaler adherence in a clinical trial. Am J Respir Crit CareMed 1995; 152: 580-88. 20.De Marco R, Cazzoletti L, Cerveri I, et al. Are the asthma gui-deline goals achieved in daily practice? A population basedstudy on treatment adequacy and the control of asthma. IntArch Allergy Immunol 2005; 138 (3): 225–34. 21.Foden J, Hand CH. Does use of a corticosteroid/long-actingbeta-agonist combination inhaler increase adherence to inha-led corticosteroids? Prim Care Respir J 2008; 17: 246e7. 22.Laube BL, Janssens HM, de Jongh FH, et al. What the pul-monary specialist should know about the new inhalation the-rapies. Eur Respir J 2011; 37: 1308e31. 23.Starobin D, Bargutin M, Rosenberg I, Yarmolovsky A, LeviT, Fink G. Asthma control and compliance in a cohort of adultasthmatics: first survey in Israel. IMAJ 2007; 9: 358–60. 24.Chapman KR, Walker L, Cluley S, Fabbri L. Improving patientcompliance with asthma therapy. Respir Med 2000; 94 (1): 2-9. 25.Sclaeppi M, Edwards K, Fuller RW, et al. Patient percepti-on of the Diskus inhaler. A comparison with the Turbuhalerinhaler. Br J Clin Pract 1996; 50: 14-19. 26.Burger M. Negative reactions to increases in perceived per-sonal control. J Pers Soc Psychol 1989; 56: 346-56.
There are 1 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | makale |
| Authors | |
| Publication Date | January 25, 2017 |
| Published in Issue | Year 2017 Volume: 9 Issue: 1 |
